Yamashita, Y., Morimoto, T., Kimura, T. (2025). Response by Yamashita et al to Letter Regarding Article, “Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)”. Circulation. https://doi.org/10.1161/circulationaha.125.075703